AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Bytey M 30mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Arrient Healthcare Pvt Ltd

Salt Composition

Gliclazide (30mg) + Metformin (500mg)

Overview Bytey M 30mg/500mg Tablet SR

Diabex Duo 30mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is vital; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are crucial for hypoglycemia management. Alcohol consumption should be minimized due to its potential to exacerbate low blood sugar. Other potential side effects are altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Bytey M 30mg/500mg Tablet SR

Diabetes mellitus type 2

Major Benefits of Bytey M 30mg/500mg Tablet SR:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the Bytey M 30mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume with food.

Common Side effects of Bytey M 30mg/500mg Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Bytey M 30mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Bytey M 30mg/500mg Tablet SR. Ingest the tablet whole; do not crush, chew, or break it. Administer this medication with food.

How Bytey M 30mg/500mg Tablet SR works:

Gliclazide and Metformin, in a 30mg/500mg sustained-release formulation (Bytey M), offer combined antidiabetic therapy.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Bytey M 30mg/500mg Tablet SR with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Bytey M 30mg/500mg SR tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Nevertheless, a physician might exceptionally prescribe it in emergencies where the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release combination of 30mg/500mg Bytey M tablets is likely not safe for breastfeeding mothers. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Bytey M 30mg/500mg SR tablets, as dose modification may be necessary. Severe kidney disease contraindicates the use of Bytey M 30mg/500mg SR tablets. Physician consultation is recommended. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Bytey M 30mg/500mg SR tablets cautiously, potentially requiring dosage modification. Individuals with mild to moderate hepatic dysfunction may begin with a reduced dose; however, use is contraindicated in those with severe liver disease. Consult your physician for guidance.

What if you forget to take Bytey M 30mg/500mg Tablet SR :

Should you forget to take a Bytey M 30mg/500mg sustained-release tablet, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Bytey M 30mg/500mg Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Bytey M 30mg/500mg Tablet SR

The extended-release tablet, Bayte M 30mg/500mg, combines gliclazide and metformin for managing type 2 diabetes mellitus in adults. This medication helps regulate blood sugar when used with a healthy diet and exercise program. Gliclazide enhances insulin secretion from the pancreas, reducing blood glucose. Metformin reduces hepatic glucose output and increases insulin effectiveness. This combination is unsuitable for type 1 diabetes.
Bytey M 30mg/500mg SR tablets are linked to several common adverse reactions. These include low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare, but potentially serious, side effects such as lactic acidosis may also occur. Prolonged use may result in vitamin B12 deficiency.
Indeed, Bytey M 30mg/500mg Extended-Release Tablets may induce hypoglycemia. Low blood sugar manifests as nausea, headache, agitation, hunger, perspiration, vertigo, tachycardia, and feelings of apprehension or tremor. This risk increases with skipped or delayed meals, alcohol consumption, strenuous activity, or concomitant use of other antidiabetic agents. Therefore, consistent blood glucose monitoring is crucial. Carry readily available glucose sources, such as glucose tablets, honey, or fruit juice.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential side effect of Bytey M 30mg/500mg Tablet SR (also known as Metformin-associated lactic acidosis or MALA). While rare, this complication is more likely in individuals with pre-existing kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Bytey M 30mg/500mg Tablet SR immediately and seek urgent medical attention.
Prolonged use of Bytey M 30mg/500mg Tablet SR can indeed lead to vitamin B12 deficiency. This is because the medication impedes the stomach's absorption of vitamin B12. Left unaddressed, this deficiency may result in anemia, neurological issues such as tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive impairment, and impaired balance (ataxia). To mitigate these risks, supplemental vitamin B12 intake, at least annually, is recommended by some studies.
Patients with hypersensitivity to any ingredient or inactive component within Bytey M 30mg/500mg Tablet SR should not use this medication. Its use is also contraindicated in individuals experiencing moderate to severe renal impairment or those with pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Bytey M 30mg/500mg SR tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar and heighten the risk of lactic acidosis.
The extended-release tablet, Bytey M 30mg/500mg, contains gliclazide and metformin. This dual-action medication manages type 2 diabetes mellitus in adults. Effective blood sugar control requires its use alongside a healthy diet and regular physical activity. Gliclazide functions by stimulating the pancreas to produce more insulin, thus reducing blood glucose. Metformin acts to decrease hepatic glucose output and enhance insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes.
Bytey M 30mg/500mg SR tablets are linked to several common adverse reactions. These include low blood sugar (hypoglycemia), taste changes, nausea, abdominal discomfort, loose stools, headache, and upper respiratory infections. Rare, but potentially serious, side effects such as lactic acidosis may also occur. Prolonged use can result in vitamin B12 deficiency.
Indeed, Bytey M 30mg/500mg Extended-Release Tablets may induce hypoglycemia. Manifestations of low blood sugar can encompass nausea, headache, irritability, hunger pangs, diaphoresis, vertigo, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is advisable.
Indeed, lactic acidosis is a potential adverse effect of Bytey M 30mg/500mg Tablet SR. This serious medical condition, characterized by excessive blood lactic acid, is also termed metformin-associated lactic acidosis (MALA). While infrequent, this side effect necessitates caution, particularly for individuals with pre-existing renal impairment, the elderly, or those consuming significant quantities of alcohol. Warning signs may manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should any of these symptoms arise, discontinue Bytey M 30mg/500mg Tablet SR use and seek immediate medical attention.
Prolonged administration of Bytey M 30mg/500mg Tablet SR may lead to vitamin B12 deficiency. This is because the medication impedes the stomach's absorption of vitamin B12. Untreated deficiency can result in anemia, neurological complications such as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive impairment, and ataxia. Preventive measures, proposed by some studies, include annual supplemental vitamin B12 intake.
Patients with hypersensitivity to any ingredient or inactive component in Bytey M 30mg/500mg Tablet SR should not use this medication. Its use is also contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol concurrently with Bytey M 30mg/500mg Tablet SR is inadvisable. This combination risks dangerously reducing blood glucose and elevates the probability of lactic acidosis.
Bytey M 30mg/500mg Tablet...
47
MRP 58
18% off